Resource center, Investors Resource center, Investors20 April 2026parDIAGNOS DIAGNOS Announces a Pilot with Opticalia in Spain Post navigation Previous PostDIAGNOS lance une étude d’essai clinique aux États-Unis Next PostDIAGNOS annonce un pilote avec Opticalia en Espagne Ressources connexe <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS Q3 2021 MDA" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 02 2021 DIAGNOS DIAGNOS Q3 2021 MDA Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS fournit une mise à jour de l’entreprise pour 2021 et des perspectives pour 2022" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 01 2022 DIAGNOS DIAGNOS fournit une mise à jour de l’entreprise pour 2021 et des perspectives pour 2022 Download PDF <img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="Validated-for-Global-Scale_-DIAGNOS-Passes-Annual-MDSAP-Audit-Solidifying-the-Pathway-to-Approvals-with-Health-Canada-FDA" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 10 2025 DIAGNOS Validated for Global Scale_ DIAGNOS Passes Annual MDSAP Audit Solidifying the Pathway to Approvals with Health Canada FDA Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-24-at-00.28.18.webp" alt="DIAGNOS Q3 2021 MDA" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Resource center Investors 02 2021 DIAGNOS DIAGNOS Q3 2021 MDA Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="DIAGNOS fournit une mise à jour de l’entreprise pour 2021 et des perspectives pour 2022" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 01 2022 DIAGNOS DIAGNOS fournit une mise à jour de l’entreprise pour 2021 et des perspectives pour 2022 Download PDF
<img src="/wp-content/uploads/2026/04/WhatsApp-Image-2026-04-23-at-12.41.28.jpeg" alt="Validated-for-Global-Scale_-DIAGNOS-Passes-Annual-MDSAP-Audit-Solidifying-the-Pathway-to-Approvals-with-Health-Canada-FDA" class="attachment-pbmit-img-890x660 size-pbmit-img-890x660 wp-post-image" width="890" height="660" > Press releases Investors 10 2025 DIAGNOS Validated for Global Scale_ DIAGNOS Passes Annual MDSAP Audit Solidifying the Pathway to Approvals with Health Canada FDA Download PDF
